Laser Artery Disease Therapy: FDA approves next-gen laser atherectomy catheter

Feb. 17, 2016
Spectranetics (Colorado Springs, CO) has received FDA 510(k) clearance for its Turbo-Power laser atherectomy catheter to treat in-stent restenosis (ISR).

Spectranetics (Colorado Springs, CO) has received FDA 510(k) clearance for its Turbo-Power laser atherectomy catheter to treat in-stent restenosis (ISR). The company notes that laser atherectomy is driving a new standard of care for treatment of coronary artery disease, with improved clinical outcomes. The tool uses vaporizing technology to maximize luminal gain-it debulks the lesion in a single step and offers remote automatic rotation for precise directional control.

About the Author

Barbara Gefvert | Editor-in-Chief, BioOptics World (2008-2020)

Barbara G. Gefvert has been a science and technology editor and writer since 1987, and served as editor in chief on multiple publications, including Sensors magazine for nearly a decade.

Sponsored Recommendations

Melles Griot Optical Systems and Semrock Optical Filters for Spatial Biology

Feb. 26, 2025
Discover why a robust, high-throughput fluorescence imaging system with Semrock optical filters is key for Spatial Biology.

Working with Optical Density

Feb. 26, 2025
Optical Density, or OD, is a convenient tool used to describe the transmission of light through a highly blocking optical filter.

Finding the Right Dichroic Beamsplitter

Feb. 26, 2025
Unsure how to select the right dichroic beamsplitter? Explore our selection guide for our wide variety of 45º dichroic beamsplitters.

Measurement of Optical Filter Spectra

Feb. 26, 2025
Learn about the limitations of standard metrology techniques and how Semrock utilizes different measurement approaches to evaluate filter spectra.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!